Community Care Behavioral Health Organization has released guidelines for treatment and recovery practices involving the use of buprenorphine, an opioid used to treat opioid addiction.
These guidelines are titled Supporting Recovery from Opioid Addiction: Best Practice Guidelines for Buprenorphine and Suboxone and are designed to aid clinicians and provider agencies. Included among the best practices are 11 "Guiding Principles for Medication-Assisted Treatment (MAT) for Opioid Addiction" that provide ideas for MAT services and recovery.
"These best practices will be a great resource for physicians and other clinicians," said James M. Schuster, MD, MBA, chief medical officer for Community Care. "Community Care hopes the best practices will promote accurate prescribing and improve the quality of treatment for persons in recovery."
In 2011, the Institute for Research, Education, and Training in Addictions (IRETA) prepared an expert panel report for Community Care regarding the use of buprenorphine. The newly released guidelines provide enhanced and current information for evidence-based treatment for Recovery-Oriented Systems of Care (ROSC). The manual incorporates information from the IRETA report, as well as current research and stakeholder input, including insights from the Buprenorphine Workgroup of the Behavioral Health Alliance of Rural Pennsylvania (BHARP).